Cancer Drug Trastuzumab And Its Biosimilars Compete On Price For Market Share-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer Drug Trastuzumab And Its Biosimilars Compete On Price For Market Share

Published:2023-06-01 Issue:6 Volume:42 Page:779-784
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Chen Alice J.¹,Kaiser Katrina M.²,Gascue Laura³,Manetas Maria-Alice⁴,Van Nuys Karen⁵

Affiliation:

1. Alice J. Chen (), University of Southern California, Los Angeles, California.

2. Katrina M. Kaiser, Caltrans, Los Angeles, California.

3. Laura Gascue, UnitedHealthcare, Los Angeles, California.

4. Maria-Alice Manetas, University of Southern California.

5. Karen Van Nuys, University of Southern California.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference12 articles.

1. Generic Drug Industry Dynamics

2. Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?

3. Variation in Biosimilar Uptake in Europe—Reply

4. The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars

5. Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Landscape of Subcutaneous Administration Strategies for Monoclonal Antibodies in Oncology;Advanced Materials;2024-08-20

2. Biosimilar drug lag and evolution in Malaysia: A retrospective analysis of regulatory approvals;2024-06-19

3. Role of supply chain intermediaries in steering hospital product choice: Group Purchasing Organizations and biosimilars;Health Affairs Scholar;2024-05-15

4. Biosimilars engage in low levels of direct-to-physician marketing relative to reference biologics;Health Affairs Scholar;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3